Literature DB >> 3310627

Antibacterial activity of sucralfate in human gastric juice.

M Tryba1, F Mantey-Stiers.   

Abstract

A series of experiments was conducted to determine the rate of bacterial growth in human gastric juice at various pH values in relation to the addition of sucralfate and antacid. Whereas the addition of antacid resulted in bacterial growth in gastric juice, sucralfate showed an antibacterial effect. This may account for the decreased rate of pneumonia among intensive-care patients who are receiving artificial ventilation and being treated with sucralfate for the prevention of stress-induced gastrointestinal bleeding compared with the rate in patients receiving conventional prophylaxis with histamine (H2)-antagonists or antacids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310627     DOI: 10.1016/0002-9343(87)90841-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  18 in total

Review 1.  Selective decontamination in intensive care practice: a review of clinical experience.

Authors:  G Ramsay; J J Reidy
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis.

Authors:  P Mahul; C Auboyer; R Jospe; A Ros; C Guerin; Z el Khouri; M Galliez; A Dumont; O Gaudin
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Gastric pH and colonisation in sucralfate treated patients.

Authors:  R Winter; A P MacGowan; D C Speller; S Willatts
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

4.  Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care.

Authors:  S Pitimana-aree; D Forrest; G Brown; A Anis; X H Wang; P Dodek
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

5.  Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients.

Authors:  G T Schumock; N P Lam; S R Winkler; S X Kong
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

6.  Stress-related Mucosal Disease.

Authors:  Mitchell J. Spirt
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

Review 7.  Prevention of hospital-acquired pneumonia in critically ill patients.

Authors:  D H Hamer; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Antibacterial activity of sucralfate versus aluminum chloride in simulated gastric fluid.

Authors:  L Welage; P Carver; K Welch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

9.  Antibacterial activity of sucralfate against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa in batch and continuous culture.

Authors:  A P West; S Abdul; M J Sherratt; T J Inglis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

10.  In vitro antibacterial activity of sucralfate.

Authors:  D Bergmans; M Bonten; C Gaillard; F van Tiel; S van der Geest; E Stobberingh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.